Camille Edwards, MD
Assistant Professor, Medicine
Biography
Dr. Edwards is an Assistant Professor of Medicine at Chobanian and Avedisian School of Medicine (BUSM). She maintains a clinical practice in hematology at Boston Medical Center (BMC) with a specific research interest in plasma cell disorders such as systemic immunoglobulin light chain (AL) amyloidosis. She is committed to improving the care of vulnerable patient populations using her translational research platform to address unanswered questions encountered in clinical care. After internal medicine residency, she completed hematology and oncology fellowship at BUSM/BMC, obtaining rigorous training through the comprehensive cancer center and the world-renowned BU Amyloidosis Center. Her current research, a collaboration with the Center for Regenerative Medicine (CReM) and BU Amyloidosis Center, focuses on using novel disease models for hematologic malignancies to study the earliest signs of disease, test treatments and develop the most promising therapeutic agents for clinical trials. She is also an active mentor for students and residents, and has a strong passion for teaching and mentoring trainees.
Publications
- Published on 4/5/2023
Horwitz MEM, Edwards CV, Athavale P, McCloskey L, Cabral HJ, Benjamin EJ, Handley MA. The STAR-MAMA RCT: Bilingual Mobile Health Coaching for Postpartum Weight Loss. Am J Prev Med. 2023 Apr 05. PMID: 37028566.
Read at: PubMed - Published on 2/28/2023
Edwards CV, Hassan H, Yildirim C, Ferri G, Verma KP, Murray Horwitz ME, Fillmore NR, Munshi NC. Peripheral blood monocyte count is a dynamic prognostic biomarker in multiple myeloma. Blood Adv. 2023 Feb 28; 7(4):482-490. PMID: 36409606.
Read at: PubMed - Published on 2/23/2023
Murray Horwitz ME, Prifti CA, Battaglia TA, Ajayi AT, Edwards CV, Benjamin EJ, Yarrington CD, Parker SE. Prepregnancy Cardiovascular Disease Risk Factors and Adverse Pregnancy Outcomes in a Safety-Net Hospital. J Womens Health (Larchmt). 2023 Apr; 32(4):401-408. PMID: 36827080.
Read at: PubMed - Published on 2/6/2023
Gandhi J, Lee MH, Adams L, Allen TS, Li J, Edwards CV. WHIM Syndrome: First Reported Case in a Patient of African Ancestry. Case Rep Hematol. 2023; 2023:3888680. PMID: 36793393.
Read at: PubMed - Published on 12/29/2022
Kaplan EH, Torabian K, Edwards CV, Kaku MC, Anand P, Lau KHV. Clinical Reasoning: A 23-Year-Old Man With Progressive Asymmetric Weakness and Numbness. Neurology. 2023 Apr 04; 100(14):674-682. PMID: 36581467.
Read at: PubMed - Published on 12/28/2022
La J, DuMontier C, Hassan H, Abdallah M, Edwards C, Verma K, Ferri G, Dharne M, Yildirim C, Corrigan J, Gaziano JM, Do NV, Brophy MT, Driver JA, Munshi NC, Fillmore NR. Validation of algorithms to select patients with multiple myeloma and patients initiating myeloma treatment in the national Veterans Affairs Healthcare System. Pharmacoepidemiol Drug Saf. 2023 May; 32(5):558-566. PMID: 36458420.
Read at: PubMed - Published on 10/27/2022
Horta LFB, Edwards CV, Kaku MC, Lau KHV. Clinical Reasoning: A 67-Year-Old Woman With Progressive Tingling Sensations and Imbalance. Neurology. 2023 Jan 17; 100(3):151-157. PMID: 36302667.
Read at: PubMed - Published on 10/1/2022
Edwards CV, Sheikh AR, Dennis MJ, Hunter A, Mackay ZP, Catudal EC, Elias R, Cabral HJ, Sarosiek SR, Tapan U. The impact of substance use on health care utilization, treatment, and outcomes in patients with non-small cell lung cancer. J Thorac Dis. 2022 Oct; 14(10):3865-3875. PMID: 36389291.
Read at: PubMed - Published on 8/12/2022
Hassan H, Verma K, Ferri G, Brauneis D, Quillen K, Sloan JM, Sanchorawala V, Edwards CV. Modified High-Dose versus High-Dose Melphalan Conditioning in Older Patients Undergoing Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis. Transplant Cell Ther. 2022 Nov; 28(11):761.e1-761.e7. PMID: 35970300.
Read at: PubMed - Published on 7/5/2022
Gustine JN, Staron A, Szalat RE, Mendelson LM, Joshi T, Ruberg FL, Siddiqi O, Gopal DM, Edwards CV, Havasi A, Kaku M, Lau KHV, Berk JL, Sloan JM, Sanchorawala V. Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25-year longitudinal study. Am J Hematol. 2022 Sep; 97(9):1189-1199. PMID: 35731907.
Read at: PubMed
View 6 more publications: View full profile at BUMC